| DM without CKD | DM with CKD | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Simple model 1 | Multiple model 1 | Simple model 2 | Multiple model 2 | Multiple model 3 | Multiple model 4 | ||||||||
 HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | ||||||||
Age | 1.00 (0.94–1.06) |  |  | 1.03 (0.99–1.06) |  |  |  |  |  |  | |||
Male vs. Female | 1.05 (0.46–2.39) |  |  | 0.97 (0.60–1.58) |  |  |  |  |  |  | |||
CCI | 1.44 (1.09–1.90)* | 1.28 (0.89–1.83) | 1.08 (0.88–1.32) |  |  |  |  |  |  | ||||
Comprehensive geriatric assessment | Â | Â | Â | Â | Â | Â | Â | Â | |||||
 MNA-SF | 0.86 (0.77–0.96)** | 1.03 (0.83–1.27) | 0.85 (0.80–0.91)** | 1.00 (0.76–1.31) | 0.97 (0.88–1.07) | 0.94 (0.86–1.04) | |||||||
 RFI ≥ 0.313 | 5.28 (2.47–11.26)** | 1.90 (0.54–6.64) | 5.92 (3.44–10.18)** | 4.01 (0.96–16.78) | 4.77 (1.98–11.49)* | 5.34 (2.23–12.80)** | |||||||
 TUG test | 1.00 (0.93–1.06) |  |  | 1.01 (0.99–1.03) |  |  |  |  |  |  | |||
 TUG test ≥ 21 s | 1.05 (0.21–5.22) |  |  | 2.50 (1.22–5.13)* | 2.98 (0.84–10.51) |  |  |  |  | ||||
 Prolonged 6 MW | 0.02 (0.00-53.10) |  |  | 0.03 (0.00-9.26) |  |  |  |  |  |  | |||
 Poor HGS | 2.82 (0.70-11.31) |  |  | 2.67 (1.12–6.37)* | 1.17 (0.31–4.42) |  |  |  |  | ||||
Laboratory data | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |||
 HgB | 0.85 (0.71–1.03) |  |  | 0.68 (0.60–0.76)** |  |  | 0.76 (0.65–0.89)** | 0.75 (0.64–0.87)** | |||||
 Albumin | 0.23 (0.13–0.43)** | 0.19 (0.07–0.53)** | 0.40 (0.31–0.52)** |  |  | 0.67 (0.40–1.10) |  |  | |||||
 Fasting glucose | 1.01 (1.003–1.01)** | 1.004 (1.0001-1.01)* | 1.00 (1.00–1.00) |  |  |  |  |  |  | ||||
 eGFR | 0.98 (0.97-1.00)* | 1.00 (0.99–1.02) | 0.98 (0.97–0.99)** |  |  | 0.99 (0.98–0.999)* | 0.99 (0.98-1.00) | ||||||
 Proteinuria | 0.99 (0.51–1.90) |  |  | 1.15 (1.04–1.26)** |  |  | 0.96 (0.84–1.09) | 1.00 (0.88–1.13) |